InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,174.00
(
1.14%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.26
(
0.09%
)
Bitcoin
61,987.25
(
0.30%
)
Post# of 1493
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LasNubes

Send PM Follow Ignore
Followers 40
Posts 2492
Boards Moderated 0
Alias Born 04/07/2012

LasNubes

Re: gixxer11 post# 1273

Tuesday, 05/12/2015 6:06:39 PM

Tuesday, May 12, 2015 6:06:39 PM

Post# of 1493
Not very likely.

It's bad press but not dangerous med.

It was sloppy leak of info by parent company.

They need to start all over because they initially thought that there was a cardiovascular benefit. The second 25% of cohort showed no benefit CV-wise but it also did not show any CV concerns.

In the long run, OREX will be fine but the bad press is brutal
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up